Huahao Zhongtian Pharmaceutical-B (02563.HK) announced mid-year financial performance, with a net loss of 54.04 million yuan, a year-on-year decrease of 23.41%.

The APP of Wisdom Financial News reports that Huahao Zhongtian Pharmaceutical-B (02563.HK) released its interim performance for the six months ending on June 30, 2025. The operating income was 14.787 million yuan, a decrease of 55.36% year-on-year; the net loss was 54.041 million yuan, a narrowing of 23.41% year-on-year; basic loss per share was 0.15 yuan.